SAI Medicine

Sai Life Sciences is a full-service contract research, development, and manufacturing organization (CRDMO) that specializes in complex small molecule drug discovery, development, and manufacturing. Established in 1999, the company collaborates with pharmaceutical and biotech firms worldwide, including seven of the top ten global pharmaceutical companies, to expedite the launch of new medicines. Their goal is to enable 25 new drug launches by 2025. The company provides a wide range of services throughout the molecular life cycle, including synthetic and medicinal chemistry, process development, scale-up chemistry, analytical development, and both cGMP and non-GMP manufacturing. Sai Life Sciences is recognized for its expertise in Chemistry, Manufacturing, and Controls (CMC) development and Key Starting Materials (KSM) supply. With a workforce of over 2,800 employees across facilities in India, the UK, the USA, and Japan, the company emphasizes strong project management to ensure effective processes throughout the project lifecycle.

• Employees 250